Intracavitary therapy of noninvasive transitional cell carcinomas of the upper urinary tract - A review of the literature

被引：10

作者：

Bassi, P ^{[1
]}

Iafrate, M ^{[1
]}

Longo, F ^{[1
]}

Iannello, A ^{[1
]}

Mostaccio, G ^{[1
]}

Ingrassia, A ^{[1
]}

Repele, M ^{[1
]}

Tavolini, IM ^{[1
]}

机构：

[1] Univ Padua, Sch Med, Dept Urol, Padua, Italy

来源：

UROLOGIA INTERNATIONALIS | 2001年 / 67卷 / 03期

关键词：

D O I：

10.1159/000050985

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

Noninvasive (stages Ta, T1, Tis) transitional cell carcinomas of the upper urinary tract are suitable for a conservative therapeutic approach. Intracavitary therapy (alone or as adjuvant treatment) has recently been proposed and successfully used by some authors. Even though bacillus Calmette-Guerin is the most frequent agent employed, chemotherapeutic drugs, such as mitomycin C and thiotepa, have also been successfully used. The current information available in the literature is therefore reviewed. According to the data available, intracavitary therapy is a worthwhile conservative therapeutic option for noninvasive upper urinary tract urotheliomas with acceptable side effects. For this reason it may be included in the routine urological armamentarium.

引用

页码：189 / 194

页数：6

共 53 条

[1]

Bales G T, 1995, Diagn Ther Endosc, V1, P121, DOI 10.1155/DTE.1.121

[2]

BASSI P, 1993, UROLOGIA, V60, P34

[3]

BASSI P, 1993, ATT 3 C NAZ SI UR O, P119

[4]

COMPLICATIONS OF INTRACAVITARY BACILLUS-CALMETTE-GUERIN AFTER PERCUTANEOUS RESECTION OF UPPER TRACT TRANSITIONAL-CELL CARCINOMA [J].